HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tommaso C. Mineo Vincenzo Ambrogi Eugenio Pompeo Permission Requests Google Scholar Articles by Mineo, T. C. Articles by Mineo, D. PubMed Articles by Mineo, T. C. Articles by Mineo, D. Related Collections Mediastinum

J Thorac Cardiovasc Surg 2009;138:40-45
© 2009 The American Association for Thoracic Surgery

General Thoracic Surgery

Recurrent intrathoracic thymomas: Potential prognostic importance of cell-cycle protein expression

^a Department of Thoracic Surgery, Policlinico Tor Vergata University, Rome, Italy
^b Department of Biochemistry and Biophysic "F. Cedrangolo," Section of Anatomic Pathology, Second University, Naples, Italy

Received for publication June 2, 2008; revisions received September 22, 2008; accepted for publication November 27, 2008.

^_* Address for reprints: Tommaso C. Mineo, MD, Cattedra di Chirurgia Toracica, Università Tor Vergata, Policlinico Tor Vergata, Via Oxford, 81, 00133 Rome, Italy. (Email: mineo{at}med.uniroma2.it).

Objective: Recurrent intrathoracic thymomas may have an unpredictable behavior. Cell-cycle protein expression has proven useful in predicting outcome in a variety of neoplasms. We investigated its potential prognostic importance in recurrent intrathoracic thymomas.

Methods: We reviewed the case histories of 25 consecutive patients operated on between 1987 and 2004 for intrathoracic recurrence (7 mediastinal, 18 nonmediastinal) after radical thymomectomy. Complete resection was performed in 14 patients. In the other 11 patients incomplete resection was followed by chemotherapy and radiotherapy. Expression of cell-cycle proteins (p53, p21, and p27) was assessed by immunohistochemistry in specimens retrieved from both initial and recurrent thymomas. Univariate and multivariate analysis for prognostic factors present at the time of the recurrence was performed.

Results: Eight of 14 patients who underwent complete resection had a second recurrence after a mean free interval of 20 ± 9 months, and a new complete resection was reperformed in 4. After incomplete resection, chemotherapy and radiotherapy allowed total remission in 4 subjects and only 1 of these had a second recurrence. Survival after surgery of the recurrence was negatively influenced by incomplete recurrence resection (P = .03), first disease-free interval less than 24 months (P = .03), high p53 (P = .04), low p21 (P = .02), low p27 (P = .003) expressions, and combination of these proteins (p53 high, p21 low, p27 low expression) (P = .0001). Multivariate analysis selected the triple combination of cell-cycle protein expression as the most significant prognostic variable (P = .02, odds ratio = 11.96, 95% confidence interval = 1.39–102.63).

Conclusions: Cell-cycle protein expression, and namely the combination of high p53, low p21, and low p27 expression, may have a potential prognostic importance in recurrent intrathoracic thymomas.